Creso Pharma (ASX:CPH) share price lifts following two positive updates

It's been a tough year for shareholders of this cannabis product developer but there's good news today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price edged higher during morning trade after the company announced the launch of new e-commerce channels and its first purchase order from Poland.

The Creso share price rose by more than 8% above yesterday's close to 13 cents, before settling back to 12 cents in mid-afternoon trade.

cannabis farmer in the fields checking the crops

Image source: Getty Images

Creso expands market presence

According to the release, Creso advised it has increased its European market presence with the launch of an e-commerce channel and marketing campaign. The online platform will sell a range of new human health products designed for sport, health and wellness.

This marks the first time Creso has utilised an e-commerce platform to unlock a new potential revenue stream.

The platform underwent a special development process with input from potential customers, suppliers and consumers. It will initially target Swiss customers and then expand throughout Europe.

Switzerland represents a large addressable market of CHF 21 billion (A$31 billion) for sports-related activities.

Creso will undertake an active marketing campaign using direct mailouts and social media targeting consumers.

The company also announced that it has received its first purchase order from Poland. The company that placed the order is the Polish medical and pharmaceutical company, Polvet.

The order consists of Creso hemp flour-based, anibidiol granule product for pets, large companion animals and livestock. Valued at roughly $80,000, the products will be used in Polvet's animal clinics and distributed through established channels.

Creso head of international operations Jorge Wernli commented:

Creso Pharma's European operations continue to grow … This represents a key strategic milestone in broadening our global footprint, as well as our presence in sports and recreational markets.

We will continue to pursue growth opportunities across Europe and can now focus on both business to business and direct to consumer paths. The Company will continue to update shareholders on progress in the coming months.

About the Creso share price

This year has been challenging for Creso shareholders. The Creso share price has fallen 33% year to date and 7.7% over the past month.

Creso has a market capitalisation of approximately $144.2 million with 1.2 billion shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A group of happy young people watching sport on a laptop celebrate.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an exceptional session for investors today.

Read more »

Smiling young parents with their daughter dream of success.
Broker Notes

Why Life360 shares could be dirt cheap and set to rise 90%

Bell Potter has good things to say about this tech stock.

Read more »

a surprised investor reading about an asx share price in a newspaper
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

The ASX just hit a rare milestone. Here's what it means for your money

ASX trading activity surges as futures volumes hit record highs.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand.
Travel Shares

Qantas stock is down 17.7% in a month. Time to buy?

Qantas is back to April prices.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Share Fallers

Why Amplitude Energy, Atlas Arteria, Computershare, and Woodside shares are falling today

These shares are falling on hump day. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Why this buy-rated ASX mining share is tipped to surge 112%

A leading broker expects this ASX mining share to more than double investors’ money in a year.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today

These shares are having a better day than most on hump day.

Read more »